BNP/CALL/STRYKER CORP./380/0.1/20.12.24 Share Price

Warrant

DE000PC5FYF5

Market Closed - Bid/Ask 07:38:04 20/06/2024 BST After market 19:33:08
1.31 EUR +6.50% Intraday chart for BNP/CALL/STRYKER CORP./380/0.1/20.12.24 1.045 -20.23%
Current month+14.95%
1 month+43.02%
Date Price Change
20/06/24 1.31 +6.50%
19/06/24 1.23 +10.81%
18/06/24 1.11 +0.91%
17/06/24 1.1 +6.80%
14/06/24 1.03 -10.43%

Delayed Quote Börse Stuttgart

Last update June 20, 2024 at 07:38 am

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying STRYKER CORPORATION
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PC5FYF
ISINDE000PC5FYF5
Date issued 21/02/2024
Strike 380 $
Maturity 20/12/2024 (183 Days)
Parity 10 : 1
Emission price 1.97
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 2.51
Lowest since issue 0.68
Spread 0.05
Spread %4.67%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
348.7 USD
Average target price
372.9 USD
Spread / Average Target
+6.96%
Consensus